8-KPRGO
Perrigo released Q3 2026 results
The press release mentioned that the company's Three-S plan is driving improvements in operating results and market share.1
PerrigoCIK 1585364Form 8-KFiled Nov 4, 2026, 6:44 AM ET0001585364-26-000160Read the filing on SEC.gov →
The company also provided non-GAAP financial measures to supplement its GAAP results.2
It also noted the expected divestiture of its Infant Formula business to focus on higher-return categories.3 A strategic review of the Oral Care business is ongoing.4
Key facts
- Company
- Perrigo (PRGO)
- CIK
- 1585364
- Form
- 8-K
- Items
- 2.02, 9.01
- Filed
- Nov 4, 2026, 6:44 AM ET
- Accession
- 0001585364-26-000160
From the EDGAR filing index, not written by AI.
Perrigo results from its filings
Revenue, net income and cash as tagged in XBRL in the company's 10-Q and 10-K filings, up to this filing. Drawn in code; no figure here is written by AI.
How often Perrigo files
Filings per calendar quarter, counted in code from the company's EDGAR filing list. Each bar splits 8-K current reports from other forms; the last bar is the quarter of this filing, counted up to it.
The numbers
| Quarter | Filings | 8-K |
|---|---|---|
| Q1 25 | 21 | 4 |
| Q2 25 | 44 | 3 |
| Q3 25 | 19 | 3 |
| Q4 25 | 6 | 1 |
| Q1 26 | 17 | 2 |
| Q2 26 | 52 | 6 |
| Q3 26 | 24 | 3 |
| Q4 26 | 3 | 2 |
Timeline
The company's filings on EDGAR around this one, newest first. Ownership forms and routine prospectus filings are left out.
Written with AI from the Perrigo Form 8-K and checked against it sentence by sentence: each of the 4 numbered sentences opens the passage it comes from. AI can make mistakes. Check the filing. Not investment advice. Not affiliated with the U.S. SEC. Source filing on SEC.gov.
